These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11205134)
1. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease. Mandel S; Grünblatt E; Youdim M J Neural Transm Suppl; 2000; (60):117-24. PubMed ID: 11205134 [TBL] [Abstract][Full Text] [Related]
2. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease? Youdim MB J Neural Transm Suppl; 2003; (65):73-88. PubMed ID: 12946050 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429 [TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. Grünblatt E; Mandel S; Maor G; Youdim MB J Neurochem; 2001 Jul; 78(1):1-12. PubMed ID: 11432968 [TBL] [Abstract][Full Text] [Related]
6. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model. Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794 [TBL] [Abstract][Full Text] [Related]
7. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
8. The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators. Youdim MB; Grünblatt E; Mandel S Ann N Y Acad Sci; 1999; 890():7-25. PubMed ID: 10668410 [TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease. Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742 [TBL] [Abstract][Full Text] [Related]
11. Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron. Youdim MB; Grünblatt E; Levites Y; Maor G; Mandel S Neurotox Res; 2002; 4(7-8):679-689. PubMed ID: 12709306 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway. Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692 [TBL] [Abstract][Full Text] [Related]
13. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease. Pattarini R; Smeyne RJ; Morgan JI Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975 [TBL] [Abstract][Full Text] [Related]
15. Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys. Campello L; Esteve-Rudd J; Bru-Martínez R; Herrero MT; Fernández-Villalba E; Cuenca N; Martín-Nieto J PLoS One; 2013; 8(9):e74439. PubMed ID: 24040246 [TBL] [Abstract][Full Text] [Related]
17. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929 [TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201 [TBL] [Abstract][Full Text] [Related]
19. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model. Hong MS; Park HK; Yang JS; Park HJ; Kim ST; Kim SN; Park JY; Song JY; Park HK; Jo DJ; Park SW; HwanYun D; Ban JY; Chung JH Neurol Res; 2010 Feb; 32 Suppl 1():74-8. PubMed ID: 20034450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]